Rich Pharmaceuticals, Inc. (OTCBB:RCHA) signed securities purchase agreement with new investor GHS Investments, LLC for private placement of a convertible promissory note for gross proceeds of $300,000 on January 5, 2017. The notes were issued at par. The note carried a coupon of 10% per annum and would mature on October 5, 2017. The notes were issued at an original issue discount of 10%, for gross proceeds of $335,000. The note is convertible into common shares at a conversion price equal to 60% of the lowest trading price during the 10-day period prior to conversion. The company paid expenses of $5,000. The company issued securities pursuant to exemption provided under Regulation D.